← Insider buys

ABMD

Abiomed Inc

No insider bought or sold Abiomed Inc in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

ABMD over the last year

Prices for ABMD aren't in yet.

ABMD after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

92 insider filings since 2016, newest first

ABMDSell

David M Weber · COO

$2.4M−5.0%Feb 18
ABMDSell

Martin P Sutter · Director

$607K−1.0%Feb 17
ABMDSell

Martin P Sutter · Director

$617K−1.0%Feb 17
ABMDSell

Martin P Sutter · Director

$1.3M−3.0%Feb 17
ABMDSell

David M Weber · COO

$3.3M−7.0%Feb 9
ABMDSell

Todd A Trapp · VP and CFO

$359K−7.0%Jan 7
ABMDSell

Martin P Sutter · Director

$7.7M−14.0%Nov 18
ABMDSell

Michael R Minogue · Chair, President and CEO

$1.2M−1.0%Aug 25
ABMDSell

Paul Thomas · Director

$219K−9.0%Aug 19
ABMDSell

Martin P Sutter · Director

$2.5M−4.0%Aug 19
ABMDSell

Michael R Minogue · Chair, President and CEO

$11.0M−6.0%Aug 10
ABMDSell

Michael R Minogue · Chair, President and CEO

$8.5M−5.0%Aug 6
ABMDSell

Michael R Minogue · Chair, President and CEO

$8.1M−5.0%Jun 23
ABMDSell

Martin P Sutter · Director

$2.0M−4.0%May 20
ABMDSell

David M Weber · COO

$4.0M−8.0%May 5
ABMDSell

Martin P Sutter · Director

$2.4M−4.0%Feb 18
ABMDSell

Dorothy E Puhy · Director

$1.7M−26.0%Feb 3
ABMDSell

Andrew J Greenfield · VP and Chief Commercial Officer

$1.6M−10.0%Feb 1
ABMDSell

Andrew J Greenfield · VP and Chief Commercial Officer

$1.8M−10.0%Feb 1
ABMDSell

Andrew J Greenfield · VP and Chief Commercial Officer

$2.1M−14.0%Dec 23
ABMDSell

Martin P Sutter · Director

$403K−1.0%Nov 19
ABMDSell

Michael R Minogue · Chair, President and CEO

$30.9M−17.0%Aug 24
ABMDSell

Martin P Sutter · Director

$468K−1.0%Aug 20
ABMDSell

Paul Thomas · Director

$607K−23.0%Aug 11
ABMDSell

Dorothy E Puhy · Director

$2.1M−28.0%Jul 17
ABMDSell

Dorothy E Puhy · Director

$1.9M−22.0%Jun 9
ABMDSell

Martin P Sutter · Director

$2.2M−6.0%May 6
ABMDSell

Paul Thomas · Director

$304K−18.0%Mar 4
ABMDSell

Paul Thomas · Director

$362K−15.0%Feb 12
ABMDSell

David M Weber · COO

$1.7M−5.0%Aug 7
ABMDSell

Martin P Sutter · Director

$1.2M−2.0%May 10
ABMDSell

Martin P Sutter · Director

$7.2M−10.0%Feb 15
ABMDSell

Martin P Sutter · Director

$10.5M−13.0%Feb 6
ABMDSell

David M Weber · COO

$8.4M−13.0%Jan 29
ABMDSell

Michael G Howley · VP, Global Sales, Marketing

$4.3M−16.0%Sep 26
ABMDSell

Andrew J Greenfield · VP Healthcare Solutions

$2.1M−9.0%Sep 26
ABMDSell

Andrew J Greenfield · VP Healthcare Solutions

$1.8M−8.0%Aug 31
ABMDSell

David M Weber · COO

$6.9M−11.0%Aug 1
ABMDSell

Michael R Minogue · Chair, President and CEO

$46.2M−16.0%Jun 25
ABMDSell

David M Weber · COO

$20.6M−21.0%Jun 19
ABMDSell

Martin P Sutter · Director

$7.5M−2.0%May 9
ABMDSell

Michael G Howley · VP, Global Sales, Marketing

$6.1M−27.0%May 9
ABMDSell

William J Bolt · SVP, QA, Regulatory Affairs

$7.9M−28.0%May 9
ABMDSell

Dorothy E Puhy · Director

$4.7M−29.0%May 9
ABMDSell

Andrew J Greenfield · VP Healthcare Solutions

$5.4M−29.0%Feb 22
ABMDSell

Dorothy E Puhy · Director

$1.1M−16.0%Nov 1
ABMDSell

Michael G Howley · VP, Global Sales, Marketing

$1.8M−18.0%Nov 1
ABMDSell

Andrew J Greenfield · VP Healthcare Solutions

$1.9M−19.0%Oct 4
ABMDSell

Eric A Md Rose · Director

$143K−7.0%Sep 1
ABMDSell

Eric A Md Rose · Director

$3.5M−65.0%Aug 28

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.